US 10646575
Heterocyclic degronimers for target protein degradation
granted A61KA61K31/4035A61K31/438
Quick answer
US patent 10646575 (Heterocyclic degronimers for target protein degradation) held by C4 THERAPEUTICS, INC. expires Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- C4 THERAPEUTICS, INC.
- Grant date
- Tue May 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/4035, A61K31/438, A61K31/439, A61K31/454